ReviewClinical science (London, England : 1979)2007

Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise.

Xiao C Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.